Results 11 to 20 of about 3,750,719 (375)

Neuropeptides as targets for the development of anticonvulsant drugs. [PDF]

open access: yesMol Neurobiol, 2014
Epilepsy is a common neurological disorder characterized by recurrent seizures. These seizures are due to abnormal excessive and synchronous neuronal activity in the brain caused by a disruption of the delicate balance between excitation and inhibition ...
Clynen E   +4 more
europepmc   +2 more sources

Function of inhibitory micronetworks is spared by Na+ channel-acting anticonvulsant drugs. [PDF]

open access: yesJ Neurosci, 2014
The mechanisms of action of many CNS drugs have been studied extensively on the level of their target proteins, but the effects of these compounds on the level of complex CNS networks that are composed of different types of excitatory and inhibitory ...
Pothmann L   +8 more
europepmc   +2 more sources

Psilocin, A Psychedelic Drug, Exerts Anticonvulsant Effects Against PTZ- and MES-Induced Seizures in Mice via 5-HT1A and CB1 Receptors: Involvement of Nitrergic, Opioidergic, and Kynurenine Pathways. [PDF]

open access: goldPharmacol Res Perspect
Balabandian M   +9 more
europepmc   +2 more sources

Targeting the Ghrelin Receptor as a Novel Therapeutic Option for Epilepsy

open access: yesBiomedicines, 2021
Epilepsy is a neurological disease affecting more than 50 million individuals worldwide. Notwithstanding the availability of a broad array of antiseizure drugs (ASDs), 30% of patients suffer from pharmacoresistant epilepsy.
An Buckinx   +3 more
doaj   +1 more source

Eslicarbazepine, but Not Lamotrigine or Ranolazine, Shows Anticonvulsant Efficacy in Carbamazepine-Resistant Rats Developed by Window-Pentylenetetrazole Kindling

open access: yesBrain Sciences, 2022
Approximately 30% of epileptic patients develop Drug-Resistant Epilepsy. Based on evidence that shows a loss of efficacy in some sodium channel blocker antiseizure drugs in epilepsy, we focus our study on assessing the anticonvulsant efficacy of ...
Cecilia Zavala-Tecuapetla   +3 more
doaj   +1 more source

WITHDRAWN. Anticonvulsant drugs for acute and chronic pain. [PDF]

open access: yesCochrane Database Syst Rev, 2010
BACKGROUND Anticonvulsant drugs have been used in the management of pain since the 1960s. The clinical impression is that they are useful for chronic neuropathic pain, especially when the pain is lancinating or burning.
Wiffen PJ   +5 more
europepmc   +3 more sources

A 14-year-old female with fever, rash, lymphadenopathy, and pancytopenia: a case report

open access: yesJournal of Medical Case Reports, 2020
Background Anticonvulsant hypersensitivity syndrome is a rare adverse drug reaction associated with aromatic anticonvulsant drugs. This syndrome can range from mild cutaneous rash to drug reaction with eosinophilia and systemic symptoms that include ...
Mojtaba Varshochi   +5 more
doaj   +1 more source

Searching for New Leads to Treat Epilepsy: Target-Based Virtual Screening for the Discovery of Anticonvulsant Agents [PDF]

open access: yes, 2018
The purpose of this investigation is to contribute to the development of new anticonvulsant drugs to treat patients with refractory epilepsy. We applied a virtual screening protocol that involved the search into molecular databases of new compounds and ...
Bruno Blanch, Luis Enrique   +8 more
core   +2 more sources

Non-invasive assessment of the effective dose of lamotrigine and topiramate for the treatment of epileptiform states in rats

open access: yesЭпилепсия и пароксизмальные состояния, 2019
Aim. This study was aimed to test the instrumental complex called «Bioscope» for its ability to determine the optimal dose of the anticonvulsant drugs lamotrigine and topiramate in the treatment of epileptiform states.Materials and methods.
R. G. Paronikyan   +7 more
doaj   +1 more source

Home - About - Disclaimer - Privacy